Cita APA

Dang, C., Ewer, M. S., Delaloge, S., Ferrero, J., Colomer, R., Cruz Merino, L. d. l., & Swain, S. M. (2022). BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer.

Citación estilo Chicago

Dang, Chau, Michael S. Ewer, Suzette Delaloge, Jean-Marc Ferrero, Ramon Colomer, Luis de la Cruz Merino, y Sandra M. Swain. BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed By Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer. 2022.

Cita MLA

Dang, Chau, et al. BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed By Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer. 2022.